Polpharma SA:企業の戦略的SWOT分析

GlobalDataが発行した調査報告書(DATA904C5348)
◆英語タイトル:Polpharma SA - Strategic SWOT Analysis Review
◆商品コード:DATA904C5348
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年9月
◆ページ数:26
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:ポーランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Polpharma SA – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Polpharma SA (Polpharma) undertakes the research, manufacture and marketing of generic drugs, prescription drugs and over the counter medications. It provides drugs in cardiology, gastroenterology and neurology areas. The company also manufactures over the counter (OTC) medications, dietary supplements, cosmetic products, medical devices and phyto-pharmaceuticals as well as active pharmaceutical ingredients (APIs). Polpharma has seven manufacturing plants in Russia, Poland and Kazakhstan. The company operates in Central and Eastern Europe, the Caucasus and Central Asia markets. Polpharma group includes Santo, Medana SA, Akrikhin Pharmaceuticals, Polfa Warszawa S.A. Polpharma is headquartered in Starogard Gdanski, Poland.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Polpharma SA – Key Facts 5
Polpharma SA – Key Employees 6
Polpharma SA – Major Products and Services 7
Polpharma SA – History 10
Polpharma SA – Company Statement 12
Polpharma SA – Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 – Company Analysis 15
Company Overview 15
Polpharma SA – Business Description 16
Polpharma SA – Corporate Strategy 17
Polpharma SA – SWOT Analysis 18
SWOT Analysis – Overview 18
Polpharma SA – Strengths 18
Polpharma SA – Weaknesses 19
Polpharma SA – Opportunities 20
Polpharma SA – Threats 21
Polpharma SA – Key Competitors 22
Section 3 – Company’s Lifesciences Financial Deals and Alliances 23
Polpharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 23
Polpharma SA, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 24
Polpharma SA, Recent Deals Summary 25
Section 4 – Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Polpharma SA, Key Facts 5
Polpharma SA, Key Employees 6
Polpharma SA, Major Products and Services 7
Polpharma SA, History 10
Polpharma SA, Other Locations 13
Polpharma SA, Subsidiaries 14
Polpharma SA, Key Competitors 22
Polpharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 23
Polpharma SA, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 24
Polpharma SA, Recent Deals Summary 25

List of Figures
Polpharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 23
Polpharma SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 24

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Polpharma SA:企業の戦略的SWOT分析(Polpharma SA - Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆